Ticker Symbol: COCP
Cocrystal Pharma Inc
$0.89 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001412486
Company Profile
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 19805 N Creek Pkwy
Website: www.cocrystalpharma.com
CEO: Gary Wilcox
Tags:
- Health Technology
- Pharmaceuticals: Generic
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.89
Change:
$0.01
(
0.53%)
Days Range: $1.81 - $1.92
Beta: 0.62
52wk. High: $3.29
52wk. Low: $1.65
Ytd. Change -3.06%
50 Day Moving Average: $1.98
200 Day Moving Average: $2.41
Shares Outstanding: 10173790
Valuation
Market Cap: 1.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A